These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 14339483)
1. [OSPOLOT IN EPILEPSY TREATMENT]. SONNENREICH C Rev Bras Med; 1965 Apr; 22():253-5. PubMed ID: 14339483 [No Abstract] [Full Text] [Related]
2. THE USE OF OSPOLOT IN TEMPORAL LOBE EPILEPSY. A PRELIMINARY COMMUNICATION. SMYTH VO Epilepsia; 1964 Sep; 5():293-5. PubMed ID: 14232251 [No Abstract] [Full Text] [Related]
3. THE USE OF OSPOLOT IN THE TREATMENT OF EPILEPSY. GORDON N Epilepsia; 1964 Mar; 5():68-73. PubMed ID: 14155207 [No Abstract] [Full Text] [Related]
4. Clinical trial of Ospolot in epilepsy. INGRAM TT; RATCLIFFE SG Dev Med Child Neurol; 1963 Jun; 5():313-5. PubMed ID: 13956541 [No Abstract] [Full Text] [Related]
5. SULTHIAMINE ("OSPOLOT") IN THE TREATMENT OF TEMPORAL LOBE EPILEPSY. SUTHERLAND JM; BOWMAN DA Med J Aust; 1963 Sep; 2():532-4. PubMed ID: 14078176 [No Abstract] [Full Text] [Related]
6. OSPOLOT IN EPILEPSY. BRAY CA; BOWER BD Dev Med Child Neurol; 1963 Aug; 5():409-11. PubMed ID: 14051583 [No Abstract] [Full Text] [Related]
7. [EXPERIENCES WITH OSPOLOT IN THE TREATMENT OF INFANTILE EPILEPSY]. DOOSE H; KLUGE D; EHMSEN U Med Klin; 1964 Feb; 59():271-4. PubMed ID: 14135761 [No Abstract] [Full Text] [Related]
8. [On the role of the butanesultam derivative Ospolot in the treatment of cerebral epilepsy]. FLUEGEL F; BENTE D; ITIL T Dtsch Med Wochenschr; 1960 Dec; 85():2199-203. PubMed ID: 13700407 [No Abstract] [Full Text] [Related]
9. OSPOLOT: a preliminary communication. HARAN T Ir J Med Sci; 1962 Sep; 441():427-31. PubMed ID: 13952703 [No Abstract] [Full Text] [Related]
10. [OSPOLOT, A NEW ANTICONVULSANT. REPORT SUMMING UP 2 YEARS OF CLINICAL TRIALS]. MELIN KA Hospital (Rio J); 1964 May; 65():1063-6. PubMed ID: 14172174 [No Abstract] [Full Text] [Related]
11. OSPOLOT--A CLINICAL TRIAL OF A NEW ANTICONVULSANT. GRIFFITHS AW; SYLVESTER PE Br J Psychiatry; 1964 Mar; 110():261-6. PubMed ID: 14130479 [No Abstract] [Full Text] [Related]
12. [Treatment of epilepsy with "ospolot"]. Teixeira I; Magalhaes G; Sztajnberg M; Pompeu F Rev Bras Med; 1966 Sep; 23(9):658-60. PubMed ID: 4385405 [No Abstract] [Full Text] [Related]
13. Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy. Olesen OV; Jensen ON Dan Med Bull; 1969 May; 16(5):154-8. PubMed ID: 4392189 [No Abstract] [Full Text] [Related]
14. [Usefulness of Ospolot in the treatment of epilepsy]. Bittner-Manicka M; Wasilewski R Neurol Neurochir Pol; 1971; 5(3):351-6. PubMed ID: 4398975 [No Abstract] [Full Text] [Related]
15. THE EFFECT OF SULTHIAME, A NEW ANTICONVULSANT DRUG IN THE TREATMENT OF TEMPORAL LOBE EPILEPSY. FENTON G; SERAFETINIDES EA; POND DA Epilepsia; 1964 Mar; 5():59-67. PubMed ID: 14155206 [No Abstract] [Full Text] [Related]
16. [Clinical and EEG study of Sulthiame (Elisal-Ospolot) in different forms of epilepsy and in petit mal]. Gayral L; Candebat L; Fourny L Encephale; 1965; 54(5):446-57. PubMed ID: 4379392 [No Abstract] [Full Text] [Related]
17. Ospolot (sulthiame) in epilepsy. (Preliminary report). Livingston S; Villamater C; Sakata Y Dis Nerv Syst; 1967 Apr; 28(4):259-63. PubMed ID: 4381572 [No Abstract] [Full Text] [Related]
18. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism. Hansen JM; Kristensen M; Skovsted L Epilepsia; 1968 Mar; 9(1):17-22. PubMed ID: 4386877 [No Abstract] [Full Text] [Related]
19. [Metabolic and anti-epileptic action of Ospolot]. Geets W; Pinon A Acta Neurol Belg; 1971; 71(2):164-72. PubMed ID: 4398951 [No Abstract] [Full Text] [Related]
20. [Experiences with Ospolot in the treatment of epilepsy]. RABE F; PENIN H; MATTHES A Dtsch Med Wochenschr; 1962 May; 87():953-9. PubMed ID: 14489576 [No Abstract] [Full Text] [Related] [Next] [New Search]